Advertisement · 728 × 90
#
Hashtag
#ANTIBODY
Advertisement · 728 × 90
Post image

Antibody Therapeutics (IF=4.5, Oxford University Press)
⚡ Research Highlight - Application of a Novel LC-MS-Based Proteomic Workflow for Host Cell Protein Monitoring and Risk Control in Biotherapeutics
academic.oup.com/abt/advance-...
#antibody #LCMS #Biotherapeutics #HostCellProtein

1 0 0 0
Preview
Epstein-Barr virus infection is causally associated with idiopathic pulmonary fibrosis: a bidirectional Mendelian randomization study Introduction: Previous studies suggest an association between herpes virus infections and idiopathic pulmonary fibrosis (IPF), but the causal relationship remains largely unclear. We used bidirection...

#antibody #idiopathicpulmonaryfibrosis #Mendelianrandomization #herpesvirus #infection

www.archivesofmedicalscience.com/Epstein-Barr...

1 0 0 0

Join the HF_lab at CSHL for cutting-edge science and advancing your career. #cryo-EM #electrophysiology #neuroscience #cancer-immunology #antibody

Postdoctoral Position in Membrane Protein Biology & Ion Channel Physiology @Lab_FURUKAWA
Cold Spring Harbor Laboratory

See the full job description on

1 0 0 0
Preview
Pfizer's trispecific antibody shows promise against eczema The pharmaceutical giant announced its candidate, tilrekimig, significantly reduced eczema severity in clinical trials.

Pfizer recently announced promising Phase II clinical trial results (NCT05995964) for its trispecific antibody product, tilrekimig, targeting eczema and other inflammatory conditions.

Read my full article below:
#eczema #antibody #pfizer

www.bioxconomy.com/modalities/p...

0 0 0 0
Preview
Increased VH4+JH6+ antibody heavy chain use in plasmablasts from asymptomatic multiple sclerosis patients - Genes & Immunity Genes & Immunity - Increased VH4+JH6+ antibody heavy chain use in plasmablasts from asymptomatic multiple sclerosis patients

🌅 #Research #alert
Increased VH4+JH6+ #antibody heavy chain use in #plasmablasts from #asymptomatic multiple #sclerosis #patients

@springernature.com #Genes & #immunity
www.nature.com/articles/s41...

0 0 0 0

#Antibody conjugation works — but needs optimization
✅ Dual functionalization? Good in vitro.
#Nanobodies? Equal targeting efficiency — but way easier & faster to produce.
#Nanomedicine #Immunotherapy #CancerResearch #Nanovaccine

0 0 1 0
Post image

What are they calling it....#TRUMP? ¯\_(ツ)_/¯
.
#Scientists created an #antibody that can #eradicate an #infection that affects 95% of the global #population.

#EpsteinBarr #virus (#EBV) is a #pervasive #pathogen, infecting nearly 95% of #humans & persisting for #life. #science #biology #health

1 0 0 0
Post image

Our NEW ReadyTector® Pure from CANDOR offers a One-Step-Detection-Solution for Immunoblots! It allows you to perform blocking, primary #antibody binding, and secondary antibody binding simultaneously, greatly simplifying and accelerating your workflow.
bocascientific.com/products/rea...

0 0 0 0
Preview
UK Sales Manager

We are looking for a high-performing sales professional to help expand our UK customer base.
📍 Remote (UK) or Cambridge
🕒 Full-time

📩 Apply: hr@antibodies.com or www.linkedin.com/jobs/view/43...

#Hiring #LifeSciences #BiotechJobs #SalesJobs #Cambrigde #Antibodies #Antibody

0 0 0 0
Post image

Today was #injection number #fortyone with #Ajovy, an #antibody for #migraine prophylaxis 💉. Number twenty-three after the break.

1 0 0 0
Preview
Novus Biologicals, TCR V beta 5 Antibody (MEM-262), Alexa Fluor 532 NB500520AF532 Human ACTB (Beta Actin) Endogenous Control (FAM™/MGB probe, non-primer limited) The Applied Biosystems™ Human ACTB (actin, beta) Endogenous…

medium.com/@genomirx/no...
Novus Biologicals, TCR V beta 5 Antibody (MEM-262), Alexa Fluor 532 NB500520AF532 @genomirx.bsky.social #alexafluor #mem262 #tcr #tcrv #antibody

1 1 0 0
Preview
Protein design: how scientists are creating tailor-made molecules to tackle major challenges | Science Arena Using computational models and AI, scientists are developing proteins to address scientific and technological challenges.

"AI isn't smart enough to provide the ultimate solution to a problem, but it's very good at finding alternative solutions," says André Teixeira, senior director of the IPI #antibody platform. Read more from Teixeira and others in this Science Arena rundown on #AI and #proteindesign.

0 0 0 0

Published in BMC #Immunology, the study found the #fungal combination was safe, reduced vaccine side effects, and did not compromise #antibody response, with antibody levels sustained and in some cases increased at six months.

2/3

12 1 1 0
Preview
Structural #insights into #antibody responses against #influenza A virus in its natural reservoir

Structural #insights into #antibody responses against #influenza A virus in its natural reservoir, etidiohnew.blogspot.com/2026/03/stru...

0 1 0 0
Preview
Scientists found a sugar that could defeat deadly superbugs Scientists in Australia have uncovered a clever new way to fight some of the most dangerous drug-resistant bacteria by targeting a sugar that exists only on bacterial cells. By designing antibodies…

"Over the next 5yrs, the team plans to turn these findings into #antibody #treatments ready for use..with a focus on #multidrug resistant A. baumannii. Achieving this goal would remove 1 of the most dangerous members of the ESKAPE #pathogens.": buff.ly/fPqV1cV

via sciencedaily
#antibiotics #MedSky

4 2 0 1
Preview
Identification of a Key #Hemagglutinin #Mutation Mediating #Antibody Escape in #Influenza #H1N1pdm09 Viruses

Identification of a Key #Hemagglutinin #Mutation Mediating #Antibody Escape in #Influenza #H1N1pdm09 Viruses,
etidiohnew.blogspot.com/2026/03/iden...

0 0 0 0
Video

#Influenza A(H3N2) subclade K, now predominant in the US, elicits lower vaccine-induced #antibody responses compared with other recent strains. These findings indicate partial immune escape and may inform future #vaccine strain selection.

ja.ma/3Pwo93y

7 2 0 0
Preview
Mpox immune test validated during Rwandan outbreak An antibody test for the infectious disease mpox was successfully developed during the new clade 1b outbreak in Rwanda, the first time that an assay of its kind has been validated within this…

#Mpox immune test validated during #Rwandan #outbreak ...

| #antibody | #ELISA | #Rwanda | #diagnostic | By @unibirmingham.bsky.social via @sciencex.bsky.social

2 1 0 0
Post image

Genetex Inc PD-L1 #recombinant #antibody has been validated for WB, ICC/IF, IHC-P and IHC-Fr & quality verified by knockdown, IFN-gamma induction & cross reactivity testing

🔗https://www.stratech.co.uk/products/GTX104763-GTX/

#immunooncology #immunohistochemistry #immunofluorescence #biotechnology

0 0 0 0
Post image

Important step for #mpox outbreak science. Validating an IgG #ELISA #antibody test during the Rwanda clade 1b #outbreak through collaboration between @unibirmingham.bsky.social RBC, University of Rwanda shows why #diagnostics must be developed where outbreaks happen www.linkedin.com/posts/drmelv...

0 0 0 0
Preview
#Vaccine-Elicited #Antibody Responses to #Influenza #H3N2 Subclade K

#Vaccine-Elicited #Antibody Responses to #Influenza #H3N2 Subclade K, etidiohnew.blogspot.com/2026/03/vacc...

1 0 0 0
Post image

From Markmann et al. in Pathogens and Immunity: "A Novel Adaptive Platform for Rapid, Simple Flow-Based Antibody Detection Devices Predicts NAb Levels to SARS-CoV-2"

Read the full article here: bit.ly/3PcEMkJ
#SARSCoV2 #COVID19 #LateralFlow #Antibody

1 1 1 0
Post image

Here you can see a crystal structure of LJF-0085 Fab, a non-human primate antibody targets HIV-1 envelope protein (PDB code: 9DMF)

Rendering by Francisco J. Enguita made with #ProteinImager

3dproteinimaging.com/protein-imag...

#SciArt #molecularart #primate #antibody #HIV #envelope #xray

2 0 0 0
Preview
The TREM2 agonistic antibody AL002 in early Alzheimer’s disease: a phase 2 randomized trial - Nature Medicine In this phase 2, randomized trial in early Alzheimer’s disease, the TREM2 agonistic antibody AL002 showed target engagement but did not meet the primary endpoint of change from baseline in Clinical De...

Results from the #INVOKE2 phase 2 trial of the #TREM2 agonistic #antibody #AL002 in early #Alzheimers disease out now. Although #AL002 showed target engagement, no change in CDR-SB was seen. #microglia #dementia #AD
www.nature.com/articles/s41...

2 2 0 0
Preview
Stabilization of the #H5 clade 2.3.4.4b #hemagglutinin improves #vaccine-elicited neutralizing #antibody responses in mice

Stabilization of the #H5 clade 2.3.4.4b #hemagglutinin improves #vaccine-elicited neutralizing #antibody responses in mice, etidiohnew.blogspot.com/2026/03/stab...

0 0 0 0
Preview
Potent efficacy of an NA-targeting #antibody against a broad spectrum of #H5N1 #influenza viruses

Potent efficacy of an NA-targeting #antibody against a broad spectrum of #H5N1 #influenza viruses, etidiohnew.blogspot.com/2026/03/pote...

0 0 0 0
Post image Post image Post image

#sugliart #divulgando #divulgazionescientifica #explorethebiology #sciencefacts #biologydaily #biolopgylover #biology #sciencecommunication #naturediscoveries #naturephotography #instascience #divulganzione #scienza #biologia #Anticorpi #antibody #intracorpi

0 0 0 0
Preview
The development of a next generation NK cell engager platform by integrating a potency-reduced IL-15 variant to enhance antitumor activity Statement of Significance Current NK cell engagers (NKCE) show limited clinical efficacy. We developed a novel tetravalent NKCE platform incorporating a re

Antibody Therapeutics(IF=4.5, Oxford University Press)
🚀🚀The development of a next generation NK cell engager platform by integrating a potency-reduced IL-15 variant to enhance antitumor activity
academic.oup.com/abt/article/...
#NKengager #IL15 #Antibody

0 0 0 0
Post image

How to design a successful multiple #immunostaining experiment with @jacksonimmunor.bsky.social conjugated #secondaryantibodies

Select the right #antibody & conjugate combination

Choose cross-absorbed antibodies and block non-specific binding

See guidelines here: tinyurl.com/nj9bdzps

0 0 0 0

See what's to come in the next issue of ASH Clinical News! Below, Dr. Samuelson Bannow previews the March issue, with highlights including articles on #AI within medical education, #cytopenia concerns with #BCMA #bispecific #antibody use, and more: https://ow.ly/pK1i50Yl7R5
#HemeSky #MedSky

0 0 0 0